Literature DB >> 4309802

Pseudohypoparathyroidism: defective excretion of 3',5'-AMP in response to parathyroid hormone.

L R Chase, G L Melson, G D Aurbach.   

Abstract

Urinary excretion of cyclic adenosine 3',5'-monophosphate (3',5'-AMP) was tested in normal subjects and patients with pseudohypoparathyroidism, idiopathic hypoparathyroidism, surgical hypoparathyroidism, and pseudopseudohypoparathyroidism under basal conditions and after a 15 min infusion of purified parathyroid hormone. Basal excretion of the nucleotide was less than normal in the patients with hypocalcemic disorders and greater than normal in pseudopseudohypoparathyroidism. Parathyroid hormone caused a marked increase in excretion of 3',5'-AMP in all subjects except those with pseudohypoparathyroidism; nine patients with this disorder did not respond to the hormone and four showed a markedly deficient response. Radioimmunoassay showed that parathyroid hormone circulated in increased amounts in plasma from patients with pseudohypoparathyroidism and became undetectable when serum calcium was increased above 12 mg/100 ml. Suppression of parathyroid hormone secretion by induction of hypercalcemia did not alter the deficient response to exogenous hormone. The results indicate that: (a) parathyroid hormone circulates in abnormally high concentrations in pseudohypoparathyroidism and secretion of the hormone responds normally to physiological control by calcium; (b) testing urinary excretion of 3',5'-AMP in response to infusion of purified parathyroid hormone appears to be an accurate and sensitive index for establishing the diagnosis of pseudohypoparathyroidism; and (c) the metabolic defect of the disorder can be accounted for by a lack of or defective form of parathyroid hormone-sensitive adenyl cyclase in bone and kidney.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4309802      PMCID: PMC322419          DOI: 10.1172/JCI106149

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  33 in total

1.  Albright's hereditary osteodystrophy comprising pseudohypoparathyroidism and pseudo-pseudohypoparathyroidism. With a report of two cases representing the complete syndrome occurring in successive generations.

Authors:  J B MANN; S ALTERMAN; A G HILLS
Journal:  Ann Intern Med       Date:  1962-02       Impact factor: 25.391

2.  Parathyroid function and the renal excretion of 3'5'-adenylic acid.

Authors:  L R Chase; G D Aurbach
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

3.  Parathyroid hormone-like action of N6-2'-O-dibutyryladenosine-3'5' (cyclic)-monophosphate on bone explants in tissue culture.

Authors:  G Vaes
Journal:  Nature       Date:  1968-08-31       Impact factor: 49.962

4.  Regulation of parathyroid hormone secretion: proportional control by calcium, lack of effect of phosphate.

Authors:  L M Sherwood; G P Mayer; C F Ramberg; D S Kronfeld; G D Aurbach; J T Potts
Journal:  Endocrinology       Date:  1968-11       Impact factor: 4.736

5.  Impairment of olfaction and of the tastes of sour and bitter in pseudohypoparathyroidism.

Authors:  R I Henkin
Journal:  J Clin Endocrinol Metab       Date:  1968-05       Impact factor: 5.958

6.  Familial pseudohypoparathyroidism. Role of parathyroid hormone and thyrocalcitonin.

Authors:  J B Lee; A H Tashjian; J M Streeto; A G Frantz
Journal:  N Engl J Med       Date:  1968-11-28       Impact factor: 91.245

7.  The effect of parathyroid hormone on adenyl cyclase in rat kidney.

Authors:  T Dousa; I Rychlík
Journal:  Biochim Biophys Acta       Date:  1968-06-24

8.  Decreased thyrocalcitonin in thyroid glands from patients with hyperparathyroidism.

Authors:  A H Tashjian; E F Voelkel
Journal:  J Clin Endocrinol Metab       Date:  1967-09       Impact factor: 5.958

9.  Assay of human thyroid glands for thyrocalcitonin activity.

Authors:  M A Aliapoulios; E F Voelkel; P L Munson
Journal:  J Clin Endocrinol Metab       Date:  1966-08       Impact factor: 5.958

10.  Renal adenyl cyclase: anatomically separate sites for parathyroid hormone and vasopressin.

Authors:  L R Chase; G D Aurbach
Journal:  Science       Date:  1968-02-02       Impact factor: 47.728

View more
  86 in total

Review 1.  Clinical spectrum and pathogenesis of pseudohypoparathyroidism.

Authors:  M A Levine
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

Review 2.  Molecular genetics of mineral metabolic disorders.

Authors:  R V Thakker
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  A case report of a 14 year old male with pseudohypoparathyroidism associated with multiple hormonal resistance.

Authors:  Prasanthi Mannava; Afshan Masood; Ambika K Devi
Journal:  Indian J Clin Biochem       Date:  2014-07-15

4.  A 6-hour human parathyroid hormone (1-34) infusion protocol: studies in normal and hypoparathyroid subjects.

Authors:  A McElduff; D Lissner; M Wilkinson; C Cornish; S Posen
Journal:  Calcif Tissue Int       Date:  1987-11       Impact factor: 4.333

5.  A simplified diagnostic test in hypoparathyroidism and pseudohypoparathyroidism type I with synthetic 1-38 fragment of human parathyroid hormone.

Authors:  K Kruse; U Kracht
Journal:  Eur J Pediatr       Date:  1987-07       Impact factor: 3.183

Review 6.  Pharmacological implications for neuroreceptor imaging.

Authors:  N P Verhoeff
Journal:  Eur J Nucl Med       Date:  1991

7.  Effect of administration of the fructose on the glycogenolytic action of glucagon. An investigation of the pathogeny of hereditary fructose intolerance.

Authors:  G Van Den Berghe; L Hue; H G Hers
Journal:  Biochem J       Date:  1973-06       Impact factor: 3.857

8.  Calcium balance in children treated with diphosphonates.

Authors:  W S Uttley; N R Belton; J Syme; H Sheppard
Journal:  Arch Dis Child       Date:  1975-03       Impact factor: 3.791

9.  Limited availability of nutritional vitamin D causing inappropriate treatment of vitamin D deficiency rickets with a response resembling pseudohypoparathyroidism type II in a Japanese patient.

Authors:  Y Inamo
Journal:  J Endocrinol Invest       Date:  2005-10       Impact factor: 4.256

10.  Increased Gsα within blood cell membrane lipid microdomains in some depressive disorders: an exploratory study.

Authors:  John J Mooney; Jacqueline A Samson; Nancy L McHale; Kathleen M Pappalarado; Jonathan E Alpert; Joseph J Schildkraut
Journal:  J Psychiatr Res       Date:  2013-03-13       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.